Following the recent explosion in the number of designs for short-term assays for mutagens and carcinogens it appears worthwhile to take stock of the current situation and speculate about future developments. Over 400 strong, weak, and noncarcinogenic compounds have been examined by one or the other of the microbial tests, Drosophila assay, or the DNA fragmentation/DNA repair system of cultured mammalian cells. Between 80 and 90o of examined carcinogens give a positive response if checked with one test. If the results of several tests are pooled, only a very few carcinogens escape detection. In spite of these highly promising results, there is a reluctance on the part of regulatory agencies to accept wholeheartedly the rapid, inexpensive, and reproducible short-term bioassays. Why? The phylogenetic relationship between bacteria and man appears for some too remote to permit an extrapolation from microbial tests to human populations. Others doubt the validity of using point mutations as an endpoint, claiming that mutations may not play a role in neoplastic transformation and thus cannot be used as a relevant endpoint.
One answer to these heretics could be to rank the various endpoints including, of course, carcinogenicity and to calculate a coefficient of rank correlation. Another answer would be to use several well chosen, short-term assays which complement each other. The Salmonella mutagenicity test in combination with activation systems (1) and the recombination assay of Kada (2) can be applied to mutagens/carcinogens found in the environment, in complex mixtures, or in body fluids of man. DNA fragmentation/DNA repair assays on cultured *Cancer Research Centre and Department of Medical Genetics, University of British Columbia, Vancouver, Canada. human cells (3) can be used to simulate conditions prevailing in man, and should, therefore, produce data of high relevance to human populations (4) . DNA fragmentation in various organs of mice or rats fed the carcinogenic compounds (5) appears to incorporate the convenience of in vitro assays with the completeness of the metabolic activation/ deactivation system of the whole animal.
In this short report we would like to point to several advantageous features of using cultured human cells as indicators and DNA fragmentation/DNA repair as endpoints. The outstanding advantage of this test system is its adaptability to situations which prevail in man, thus permitting an easy transfer of in vitro results to in vivo conditions. A few examples should illustrate this point.
Carcinogenic nitrosation products can be readily detected when nitrosation is carried out in simulated gastric juice (6) . Genetically controlled susceptibility can be uncovered by estimating the level of repair synthesis following various chemical carcinogens (7) or the reactivation of ultravioletirradiated DNA viruses (8, 9 agent (UV, 4NQO or MNNG). During this period, the cell cannot respond to a second dose with a normal level of DNA repair synthesis. In this stage the cell temporarily acquires an elevated sensitivity to the chromosome damaging action and lethal effect of chemical mutagens/carcinogens (11) .
The interaction of chemical and physical agents is another area which has received less attention than it merits, e.g., the combined use of psoralen and long ultraviolet-radiation in the treatment of psoriasis. DNA Finally, the complex interplay between chemical carcinogens, viruses and genetic composition of the target cells must be unravelled to understand the factors which enhance or reduce the risk of neoplastic transformation (13) .
In spite of the many advantages offered by the above-mentioned bioassays, there are several unresolved issues that need attention. For the sake of simplicity we have used fibroblasts obtained from small skin biopsies of normal and geneticallyafflicted persons of high cancer risk. Thus all our studies are done on fibroblasts instead of the epidermal cells from which most human tumors arise. Criticism can also be directed toward the exclusive use of cultured cells forced to grow on glass or plastic surfaces. The possibility of whether human organ pieces could be grown in immunodepressed mice which are then exposed to chemical carcinogens should be explored. This approach, if successful, would have the advantage of having human target tissue in its original form treated with chemical carcinogens.
In our opinion there is at present little to gain in the continuous introduction of new short term assays or new indicator subjects. We would rather favor the selection of a very few bioassays and proceed with their in depth analysis. Serious consideration should be given to: (I) bioassays which are the most rapid, economic and reproducible for the large-scale screening of carcinogens in man's environment and (2) bioassays which can simulate closest the conditions prevailing in man. The combination of both groups of bioassays should increase their predictive value in assessing carcinogenic hazards to human populations, and should find acceptance by regulatory agencies.
